Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Composition of microbes in the lower airways is different for patients with idiopathic pulmonary fibrosis

A new study from the University of Bergen shows that patients with Idiopathic pulmonary fibrosis (IPF) have a different composition of microbes in the lower airways than healthy controls and patients with Chronic obstructive pulmonary disease (COPD).

13 Jan 2022

Role of leptin in immune modulation and pathophysiology of COVID-19

A recent review paper in the journal Frontiers in Physiology discusses the role of leptins in infection with SARS-CoV-2 that triggered the ongoing COVID-19 pandemic.

13 Jan 2022

Simple health assessment could significantly reduce the global burden of COPD

The global burden of Chronic Obstructive Pulmonary Disease (COPD), a group of common lung conditions that affects more than 300 million people, could be significantly reduced with a simple health assessment, concludes a large-scale international study led by UCL researchers.

11 Jan 2022

New study identifies ways to detect COPD in low- and middle-income countries

How to better detect chronic obstructive pulmonary disease (COPD) in low- and middle-income countries is a question that has long plagued the global medical community.

11 Jan 2022

A new model for predicting COVID-19 severity at diagnosis

Researchers estimate the probabilities of hospitalization and mortality from COVID-19 according to individual risk factors and number of vaccine doses.

5 Jan 2022

Scientists analyze the causes of deaths and disabilities in Colorado over a 29-year period

Scientists at Colorado State University used one of the most comprehensive global health datasets in the world to analyze the causes of deaths and disabilities in Colorado over a 29-year period, from 1990 to 2019.

3 Jan 2022

Race-based formula used to diagnose lung disease should be changed, study suggests

New results from a long-term epidemiologic study reveal that one of the oldest racially based diagnostic formulas in medicine is no better than a race-neutral equation, which suggests the formula used to diagnose lung disease should be changed.

16 Dec 2021

Impact of tumor environments on susceptibility and course of disease in those infected with SARS-CoV-2

A review assessed the impact of "hot" vs. "cold" immune/tumor environments (and associated therapies) on susceptibility and disease course in subjects with these two types of tumors and infected with SARS-CoV-2 to decipher the mechanisms that drive these adverse outcomes in COVID-19 infected cancer patients.

13 Dec 2021

Efficacy of BNT162b2 vaccine booster in reducing mortality due to COVID-19

A recent observational study in Israel evaluates the efficacy of a Pfizer vaccine booster dose in reducing the mortality rate of COVID-19.

12 Dec 2021

A rural Georgia community reels after its hospital closes

Lacandie Gipson struggled to breathe. The 33-year-old woman with multiple health conditions was in respiratory distress and awaiting an ambulance. About 20 minutes after the emergency call, it arrived.

10 Dec 2021

Study identifies small RNA molecule as a therapeutic target for COPD

Research led by the Centenary Institute and University of Technology Sydney (UTS) has identified a small RNA molecule called microRNA-21 as a therapeutic target and its inhibition as a potential treatment for chronic obstructive pulmonary disease (COPD).

24 Nov 2021

Researchers provide a clearer picture of healthy development of the lungs

Researchers have compiled the most comprehensive road map of the protein composition of human lungs, providing a clearer picture of the healthy development of this essential organ that made terrestrial life possible.

18 Nov 2021

The antiviral function of BET protein against SARS-CoV-2 infection

Considering the past shreds of evidence on BRD2 and BRD4 associated with viral infections, researchers have recently evaluated the function of all relevant BET proteins during COVID-19 infection.

17 Nov 2021

Inhaled prostacyclin improves oxygenation in acute respiratory distress syndrome patients

The findings reveal that inhaled prostacyclin significantly improves oxygenation in ARDS patients who had COVID-19. The study is currently available on the medRxiv* preprint server.

17 Nov 2021

New therapy targets rodents' cells rather than bacterial cells in treating pneumonia

Researchers at the National Institutes of Health have discovered a therapy that targets host cells rather than bacterial cells in treating bacterial pneumonia in rodents.

15 Nov 2021

Updated mapping of the human genetic architecture of COVID-19

In the present study, researchers presented extensive meta-analysis and added ten new genome-wide significant loci.

15 Nov 2021

Potential therapeutic targets of hydrogen for treatment of the COVID-19

A recent article provided a review of a study led by academician Zhong Nanshan, in China, on COVID-19 treatment by inhalation of a mixed gas composed of hydrogen and oxygen.

12 Nov 2021

Will the future of global health rely upon addressing air pollution?

We speak to Dr. Philip Landrigan about his latest research into air pollution and how African countries are in a prime position to take action against it.

12 Nov 2021

Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19

In an attempt to study the safety and effectiveness of sotrovimab in more vulnerable patients suffering from mild to moderate symptoms of COVID-19, a multinational team of researchers conducted the COVID-19 Monoclonal antibody Efficacy Trial-Intent to Care Early (COMET-ICE) trial.

11 Nov 2021

People of color, lower-income residents in DC disproportionally affected by air pollution

The rates of death and health burdens associated with air pollution are borne unequally and inequitably by people of color and those with lower household income and educational attainment in Washington, D.C., according to a new study.

8 Nov 2021

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Composition of microbes in the lower airways is different for patients with idiopathic pulmonary fibrosis

Role of leptin in immune modulation and pathophysiology of COVID-19

Simple health assessment could significantly reduce the global burden of COPD

New study identifies ways to detect COPD in low- and middle-income countries

A new model for predicting COVID-19 severity at diagnosis

Scientists analyze the causes of deaths and disabilities in Colorado over a 29-year period

Race-based formula used to diagnose lung disease should be changed, study suggests

Impact of tumor environments on susceptibility and course of disease in those infected with SARS-CoV-2

Efficacy of BNT162b2 vaccine booster in reducing mortality due to COVID-19

A rural Georgia community reels after its hospital closes

Study identifies small RNA molecule as a therapeutic target for COPD

Researchers provide a clearer picture of healthy development of the lungs

The antiviral function of BET protein against SARS-CoV-2 infection

Inhaled prostacyclin improves oxygenation in acute respiratory distress syndrome patients

New therapy targets rodents' cells rather than bacterial cells in treating pneumonia

Updated mapping of the human genetic architecture of COVID-19

Potential therapeutic targets of hydrogen for treatment of the COVID-19

Will the future of global health rely upon addressing air pollution?

Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19

People of color, lower-income residents in DC disproportionally affected by air pollution

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in